WATCH TV LIVE

Tags: moderna | oriciro | mrna | covid

Moderna Snaps Up Japan's OriCiro in MRNA Push

(AP)

Wednesday, 04 January 2023 08:27 AM EST

Moderna Inc. Wednesday agreed to buy Japan-based OriCiro Genomics for $85 million to boost the U.S. drugmaker's messenger RNA (mRNA) manufacturing capabilities.

The Japanese company is working on the development and commercialization of cell-free synthesis and amplification of a type of DNA molecule for use in mRNA manufacturing.

OriCiro's technologies will support Moderna's portfolio of therapeutics and vaccines, the companies said.

Moderna's mRNA technology has been used in developing COVID-19 vaccines.

Last month, an experimental cancer vaccine from Moderna based on the technology was shown to work against melanoma, a type of skin cancer.

Click Here to comment on this article

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

Yes, Send Me News Alerts via email

(Optional for Local News)

Privacy: We never share your email address.

Join the Newsmax Community

Read and Post Comments
Please review Community Guidelines before posting a comment.

TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.